Latest Quest Diagnostics Incorporated Stories
MADISON, N.J., June 6, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President and CEO, presented at the Jefferies 2013 Global Healthcare Conference in New York City today. During the presentation, Mr. Rusckowski reaffirmed the company's guidance for its results from continuing operations, before special items, for the full-year 2013: Revenues are expected to...
Collaboration features national availability of the APTIMA HPV mRNA-based cervical cancer screening test as well as a focus on developing and expanding access to diagnostic solutions for women's health MADISON, N.J. and BEDFORD, Mass., June 6, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical...
MADISON, N.J., June 5, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President and CEO, is scheduled to speak at the Jefferies 2013 Global Healthcare Conference in New York City on Thursday, June 6, 2013 at 1:00 p.m. Eastern Time. During the conference, Mr. Rusckowski will reaffirm the company's full-year 2013 guidance. Revenues are expected to approximate the...
MADISON, N.J., May 7, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas. The presentation is scheduled for Wednesday, May 15, 2013 at 11:40 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site:...
MADISON, N.J., April 17, 2013 /PRNewswire/ -- Adjusted diluted EPS from continuing operations of $0.89, vs. $1.05 in 2012 Reported diluted EPS from continuing operations of $0.72, vs. $0.97 in 2012 Revenues from continuing operations of $1.8 billion, 6.4% below prior year Full year 2013 adjusted EPS and cash flow guidance unchanged Full year 2013 revenues now expected to approximate the prior year level Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
MADISON, N.J., April 16, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced today that Jim Davis, a former vice president for three GE healthcare businesses, has joined Quest Diagnostics as Senior Vice President, Diagnostic Solutions. In this role, Mr. Davis will lead the company's Diagnostic Solutions business. In this role, he will oversee Diagnostic Products, Insurer Services, Clinical Trials and Healthcare...
MADISON, N.J., March 14, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Robert A. Hagemann, Senior Vice President and Chief Financial Officer, plans to leave the company at the end of May 2013. The company is launching a search for a new CFO that will consider both internal and external candidates, and Mr. Hagemann will assist in identifying his successor. Mr. Hagemann will continue in his...
MADISON, N.J. and SAN CARLOS, Calif., Feb. 20, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Natera, a leading innovator in prenatal genetic testing, today announced that Quest Diagnostics will offer physicians access to Panorama(TM), a new non-invasive prenatal test developed by Natera. Panorama uses cell-free fetal DNA in circulating maternal blood to screen for chromosomal abnormalities associated with...
MADISON, N.J., Feb. 8, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Leerink Swann Global Healthcare Conference in New York City. The presentation is scheduled for Thursday, February 14, 2013 at 11:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site:...
MADISON, N.J., Jan. 23, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the fourth quarter ended December 31, 2012, adjusted income from continuing operations was $163 million, or $1.01 per diluted share, compared to adjusted income from continuing operations of $191 million, or $1.20 per diluted share, for 2011. In the fourth quarter of 2012, as previously announced,...
